Insights

Strategic collaborations Lonza is actively pursuing partnerships to enhance vaccine formulation stability and delivery (e.g., collaboration with Ethris on room-temperature spray-dried mRNA vaccines), presenting sales opportunities in advanced formulation technologies, mucosal delivery platforms, and scalable manufacturing support.

Digital integration Adoption of data and automation tools (Azure Databricks, Qlik, Tableau, Talend, Workday, Smartsheet, Asana) indicates a maturity in digital operations, suggesting opportunities to provide integrated data analytics, digital workflows, and cloud-enabled CDMO process optimization services.

End-to-end automation Recent integration of MODA-EM with Rapid Micro Biosystems for paperless microbial enumeration across multiple US sites signals a demand for end-to-end automated QA/QC solutions, lab informatics, and faster batch release capabilities.

Workforce and training Lonza’s biomanufacturing apprenticeship program and expanded workforce initiatives create avenues to offer workforce development services, specialized training platforms, and manufacturing talent pipelines for scale-up projects.

Leadership and governance Leadership changes in legal and corporate affairs, plus strategic IBM collaboration on data models, indicate a focus on compliance, governance, and data-driven supply chain optimization—areas where services in risk management, regulatory intelligence, and supply chain analytics can add value.

Similar companies to Lonza

Lonza Tech Stack

Lonza uses 8 technology products and services including Azure Databricks, Qlik, Tableau, and more. Explore Lonza's tech stack below.

Media & News

Lonza's Email Address Formats

Lonza uses at least 4 email formats:
Lonza Email FormatsExamplePercentage
First.Last@lonza.comJohn.Doe@lonza.com
95%
Last.First@lonza.comDoe.John@lonza.com
2%
First.Middle@lonza.comJohn.Michael@lonza.com
2%
FL@lonza.comJD@lonza.com
1%

Frequently Asked Questions

What is Lonza's phone number?

Minus sign iconPlus sign icon
You can contact Lonza's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Lonza's stock symbol?

Minus sign iconPlus sign icon
Lonza is a publicly traded company; the company's stock symbol is 0QNO.L.

What is Lonza's official website and social media links?

Minus sign iconPlus sign icon
Lonza's official website is lonza.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Lonza generate?

Minus sign iconPlus sign icon
As of October 2026, Lonza's annual revenue is estimated to be $1B - $10B.

What is Lonza's SIC code and NAICS code?

Minus sign iconPlus sign icon
Lonza's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Lonza have currently?

Minus sign iconPlus sign icon
As of October 2026, Lonza has approximately 19K employees across 6 continents, including Europe, North America and Asia. Key team members include Chief Executive Officer: W. W., Chief Executive Officer: J. L. and Ceo: M. M. Explore Lonza's employee directory with LeadIQ.

What industry does Lonza belong to?

Minus sign iconPlus sign icon
Lonza operates in the Pharmaceutical Manufacturing industry.

What technology does Lonza use?

Minus sign iconPlus sign icon
Lonza's tech stack includes Azure Databricks, Qlik, Tableau, Talend, Workday, Asana, Smartsheet and Piwik PRO Core.

What is Lonza's email format?

Minus sign iconPlus sign icon
Lonza's email format typically follows the pattern of First.Last@lonza.com. Find more Lonza email formats with LeadIQ.

How much funding has Lonza raised to date?

Minus sign iconPlus sign icon
As of October 2026, Lonza has raised $445M in funding. The last funding round occurred on Nov 06, 2023 for $445M.

When was Lonza founded?

Minus sign iconPlus sign icon
Lonza was founded in 1897.
Lonza logo

Lonza

Pharmaceutical ManufacturingBasel-Stadt, Switzerland10001+ Employees

Lonza operates as a contract development and manufacturing organization in the pharmaceutical sector, turning customers' innovations into viable therapies and scalable medicines. Based in Basel, Basel-Stadt, it maintains a global presence and emphasizes quality, safety, and reliability to bring life-enhancing treatments to market.

The company serves biopharma and biotech developers seeking integrated development and manufacturing solutions for complex products. As a well-established Western CDMO, it holds a leading position in the industry through its combination of scientific capability and lean manufacturing. In 2025 Lonza announced a strategic collaboration with IBM to develop data-driven models using external chemical repositories and its own supply-chain data.

Section iconCompany Overview

Phone number
Website
lonza.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
0QNO.L
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1897
Employees
10001+

Section iconFunding & Financials

  • $445M

    Lonza has raised a total of $445M of funding over 1 rounds. Their latest funding round was raised on Nov 06, 2023 in the amount of $445M as a Post IPO Debt.

  • $1B - $10B

    Lonza's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.